These are some of the emerging contracts, broad agency announcements, other transaction consortia, and grants applicable to COVID-19 response so far…
More info: https://aida.mitre.org/covid/
Department of Defense
DoD/DHHS via Joint Program Executive Office for Chemical and Biological Defense (JPEO-CBD) sponsored MCDC Other Transaction Consortium:
RFI: CoV Pandemic Response
Focus areas include:
Diagnostics/Monitoring
Surveillance
Information Systems for Point of Care
Therapeutics
Prophylactics
Clinical Trials
RPP 20-04: Advance Treatment Based on Polyclonal Antibodies to Treat Coronavirus Disease
U.S. Army Medical Research and Development Command (USAMRDC) Medical Technology Enterprise Consortium (MTEC):
Pre-Announcement for Potential RPPs for Prototype Development to Combat Novel Coronavirus Disease COVID-19
Focus areas include:
Point-of-care diagnostic that provides rapid and accurate determination on exposure to COVID-19.
Prophylactic(s)/Therapeutic(s) that can prevent and/or treat in a rapid manner (few hours to 2 days) potentially in a non-hospital environment. Repurposing FDA-approved drugs/biologics for prevention/treatment of COVID-19 or testing of drugs/biologics that have already demonstrated safety in humans for the prevention/treatment of COVID-19 are preferred.
Disease predictive modeling that provides early warning through data capture from several different streams of data to include social media and artificial intelligence (AI) parameter decision tools that would provide actionable information to medical service providers and command structures.
Patient monitoring, tracking, and management system for in-home or non-hospital environment patient tele-health services to include interface into the Cerner electronic health record.
Health and Human Services
Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA):
COVID-19 response related Areas of Interest:
AOI 7.7.1 Diagnostic assay for human coronavirus using existing FDA-cleared platforms
AOI 7.7.2 Point-of-care diagnostic assay for detection of SARS-CoV-2 virus
AOI 7.7.3 Diagnostic assay for detection of COVID-19 disease (SARS-CoV-2 infection)
AOI 8.3 COVID-19 Vaccine
AOI 9.2 COVID-19 Therapeutics
AOI 9.3 Immunomodulators or therapeutics targeting lung repair
AOI 9.5 Pre-exposure and post-exposure prophylaxis
AOI 10 Respiratory protective devices
AOI 11 Ventilators
AOI 17 Advanced Manufacturing Technologies
Center for Disease Control (CDC) Grant: CDC-RFA-OT18-18020202SUPP20
Supplemental funding for the organizations that were previously awarded funding under Funding Strategy 1 of CDC-RFA-OT18-1802: “Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation’s Health” in FY18.
This supplemental funding opportunity enables recipients to provide capacity-building assistance (CBA) activities in support of COVID-19 preparedness and response efforts. The goal is to fund recipients that have the capability, expertise, resources, reach, and history of providing capacity building relevant to implementing this program’s key strategies, activities, and outcomes, as they relate to the following emergency preparedness domains:
Strengthen Incident Management for Early Crisis Response
Strengthen Jurisdictional Recovery
Strengthen Biosurveillance
Strengthen Information Management
Strengthen Countermeasures and Mitigation
Strengthen Surge Management
Strengthen Communications
Achieve Incident Management System Response Objectives
Center for Disease Control (CDC) State, Local, Territory, and Tribe (SLTT) funding through Crisis Cooperative Agreement (CoAg):
Resources directed for grants or cooperative agreements to states, localities, territories, and tribes to accelerate planning and operational readiness for COVID-19 preparedness and response, as well as develop tools and strategies, provide technical assistance and program support, as well as ensure ongoing communication and coordination among public health agencies and partners throughout the response
Department of Homeland Security
Federal Emergency Management Agency (FEMA)
Emergency Management Performance Grant (EMPG) Program Notice of Funding Opportunity (NOFO)
All 56 states and territories, as well as the Republic of the Marshall Islands and the Federated States of Micronesia (collectively “state or territory”), are eligible to apply for FY 2020 EMPG Program funds.
Veterans Affairs
VA Federal Supply Schedule
Under delegated authority by GSA, the VA manages multiple award contracts for medical equipment, supply, pharmaceutical, and service Schedule programs.
Presidential Declaration of National Emergency COVID-19 – State and Local Government Ordering Procedures
Emergency declaration for all states, tribes, territories, and the District of Columbia pursuant to section 501 (b) of the Robert T. Stafford Disaster Relief and Emergency Assistance Act, 42 U.S.C. 5121-5207 (the “Stafford Act”). Based upon this declaration, full access to order against Federal Supply Schedules, including VA Schedules, is available to State and Local Governments.
General Services Administration
Purchasing for Disaster Recovery
Federal agencies, state, and local agencies, under the GSA Disaster Recovery Purchasing Program, can acquire supplies and equipment from our online shopping and ordering system at GSAAdvantage!®.
State and Local Disaster Purchasing
Allows state and local governments to buy supplies and services directly from all GSA Schedules to facilitate disaster preparation, response, or major disaster recovery.
GSA Pandemic Purchasing
GSA can assist federal agencies find the policies, products, and services they need in a time of national crisis or emergency.
Law Enforcement and Security Services (Federal Protective Services)
Medical Equipment and Supplies Schedule 65 II A (Schedules eLibrary)
Online shopping for Supplies and Services through GSAAdvantage!® Disaster Relief Products and Services
Medical Supplies (first aid kits, resuscitation products, wound care products, body bags, lifts/ stretchers)
Personal Safety & Protection (safety apparel/footwear; respiratory, vision, hearing, and head protection)
Cleanup Supplies (disinfectants, water treatments, brooms/mops, waste containers, buckets, trash bags)
Medical and Laboratory Services (technical, professional, general support)
Environmental Services (chemical analysis, waste management, recycling)